Dr. Ballester is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
903 Providence Pl #443
Providence, RI 02903Phone+1 518-728-1709
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 1988 - 1988
- Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 1977 - 1980
- Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 1973 - 1974
- Huron HospitalInternship, Transitional Year, 1972 - 1973
- Universidad Nacional de CordobaClass of 1971
Certifications & Licensure
- IA State Medical License 2013 - 2013
- WV State Medical License 2007 - 2012
- LA State Medical License 2007 - 0
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer Start of enrollment: 1997 Oct 01
- Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) Start of enrollment: 2008 Aug 01
- Aplidin - Dexamethasone in Relapsed/Refractory Myeloma Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- 61 citationsHigh-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.O. F. Ballester, R Tummala, William E. Janssen, Karen K. Fields, John W. Hiemenz
Bone Marrow Transplantation. 1997-10-01 - 21 citationsNon-Hodgkin's lymphoma in the older person : a reviewO. F. Ballester, Lynn C. Moscinski, A. S. D. Spiers, Lodovico Balducci
Journal of the American Geriatrics Society. 1993-11-01 - 470 citationsLong-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.James R. Berenson, Alan Lichtenstein, Lester Porter, Meletios A. Dimopoulos, Roldolfo Bordoni
Journal of Clinical Oncology. 1998-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: